Argatroban Injection 250 mg/2.5 mL (100 mg/mL) Recall
Argatroban Injection 250 mg/2.5 mL (100 mg/mL)
What does the FDA announcement say about status?
This FDA-published company announcement reports the recall and its instructions. It does not supply an FDA enforcement classification or a live recall-completion status. Follow the announcement and contact the firm for current guidance.
What is the scope of this recall record?
The announcement publishes 22 lot and expiry pairs. Match the complete product, package NDC, lot number and expiration date against the official announcement.
This announcement was last checked on 2026-10-19. The company's announcement date, FDA publication date and this site's first observation are recorded separately.
Why was Argatroban Injection 250 mg/2.5 mL (100 mg/mL) recalled?
Presence of particulate matter, identified as cellulose, polystyrene, polyethylene terephthalate, stopper material, and possibly stainless steel
What should I do if I have this product?
Follow the company's instructions in the official FDA announcement.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Which lot codes, UPCs or models are affected?
NDC 42023-182-01; lot 83449; expiry 10/2026 NDC 42023-182-01; lot 82682; expiry 11/2026 NDC 42023-182-01; lot 86714; expiry 02/2027 NDC 42023-182-01; lot 87302; expiry 02/2027 NDC 42023-182-01; lot 87560; expiry 02/2027 NDC 42023-182-01; lot 87753; expiry 03/2027 NDC 42023-182-01; lot 88401; expiry 03/2027 NDC 42023-182-01; lot 88614; expiry 04/2027 NDC 42023-182-01; lot 88836; expiry 04/2027 NDC 42023-182-01; lot 90220; expiry 05/2027 NDC 42023-182-01; lot 91216; expiry 06/2027 NDC 42023-182-01; lot 91219; expiry 06/2027 NDC 42023-182-01; lot 92004; expiry 07/2027 NDC 42023-182-01; lot 92006; expiry 07/2027 NDC 42023-182-01; lot 92009; expiry 08/2027 NDC 42023-182-01; lot 92596; expiry 08/2027 NDC 42023-182-01; lot 92782; expiry 08/2027 NDC 42023-182-01; lot 93107; expiry 08/2027 NDC 42023-182-01; lot 93329; expiry 08/2027 NDC 42023-182-01; lot 93890; expiry 09/2027 NDC 42023-182-89; lot 84193; expiry 10/2026 NDC 42023-182-89; lot 92880; expiry 08/2027
- FDA announcement ID
- 430133
- Product
- Argatroban Injection 250 mg/2.5 mL (100 mg/mL)
- Recalling firm
- Par Health USA, LLC
- FDA published
- October 14, 2026
- Company announced
- October 13, 2026
- First observed by this site
- October 15, 2026
- Agency
- FDA (drug)